MedPath

Effect of High Dose Inhale and Nebulize Budesonide Added to Standard Treatment in Children with Acute Asthma

Conditions
asthma exacerbation in childhood asthma
acute asthma, asthma exacerbation, budesonide, admit, length of stay, cost
Registration Number
TCTR20230427001
Lead Sponsor
Faculty of Medicine, Thammasat University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
92
Inclusion Criteria

1) 1-18 years of age with a history of diagnosed asthma or at least 2 episodes of wheezing that responding to bronchodilators, all severity
2) Asthma patients who treated with standard drugs according to GINA guidelines

Exclusion Criteria

1) Acute Asthma patients who received others treatment such as high dose inhaled fluticasone propionate, 3%NACl, Adrenaline nebulization at ER or OPD
2) patients who have comorbidity or underlying disease such as chronic cardiopulmonary disease, Congenital lung/ airways anomalies, Bronchopulmonary dysplasia
3) Patients who missing information in medical records
4) Patients with acute exacerbation of asthma whose symptoms occur while being hospitalized are inpatients.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath